Geneva, Sept. 25 -- International Clinical Trials Registry received information related to the study (NCT07821944) titled 'A Clinical Study of Enlicitide (MK-0616) in Adults With Hyperlipidemia in India (MK-0616-038)' on Sept. 9.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Investigator, Outcomes Assessor).
Primary Sponsor: Merck Sharp & Dohme LLC
Condition:
Hyperlipidemia
Hypercholesterolemia
Intervention:
Drug: Enlicitide Decanoate
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: October 16, 2026
Target Sample Size: 150
To know more, visit https://clinicaltrials.gov/study/NCT0...